ArticlePathogens (Basel, Switzerland)2026
Evaluation of a Commercial Ozonated Olive Oil Product (800 mEq O
Article in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMethicillin-resistant
objectiveWe aimed to evaluate the efficacy of commercial ozonated olive oil product (800 mEq O MATERIALS AND
methodsIn vitro susceptibility testing determined minimum inhibitory concentrations (MIC) and time-kill kinetics. Subsequently, canine skin samples were mounted in Franz diffusion cells, inoculated with MRSP (~10
resultsIn vitro testing demonstrated antibacterial activity for ozonated oil (MIC < 20%
conclusionsDespite in vitro activity, this ozonated olive oil failed to reduce MRSP in ex vivo skin, revealing that tissue barriers prevent antibacterial delivery. These findings demonstrate that in vitro screening cannot predict topical efficacy and emphasize the necessity of tissue-based validation before clinical use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.